Pill for babies: trial aims to swap painful insulin shots for oral medicine
NCT ID NCT00610038
Summary
This study tested if babies with a rare, permanent form of diabetes caused by specific genetic mutations could safely switch from daily insulin injections to an oral pill called glibenclamide. It involved 19 infants and young children to see if the pill could control their blood sugar as well as insulin. Researchers also checked if the pill might improve any related neurological or developmental issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Necker Hospital - Endocrinology Gynecology Pediatric unit
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.